Pruritus reduction via anti-inflammatory botanical extracts

"Pruritus reduction via anti-inflammatory botanical extracts" refers to the use of plant-derived compounds or herbal formulations to alleviate itching through anti-inflammatory, antioxidant, and immunomodulatory mechanisms. These extracts—found in plants like chamomile, aloe vera, curcumin, and licorice—are shown to inhibit pro-inflammatory cytokine release, reduce oxidative stress, modulate immune cell signaling, and improve skin barrier function, collectively leading to reduced itch intensity. This strategy engages multiple, heterogeneous targets at the molecular and cellular levels, rather than a single well-defined therapeutic molecule or receptor[1][2][5][7]. Clinical studies highlight variability in efficacy and underline the need for standardization and further research into safety profiles. This entry is *not* a molecular target but a description of a polypharmacological approach involving multiple, sometimes undefined, targets and mechanisms. It should not be treated as a specific receptor, enzyme, or protein. More appropriate target entries for structuring would be individual molecules (e.g., "Interleukin-31 receptor," "Histamine H4 receptor," etc.) or specific bioactive phytochemicals.

Other names

anti-inflammatory plant extractsantipruritic phytochemicals

These botanicals operate through diverse mechanisms, including: - Inhibition of pro-inflammatory cytokines (e.g., TNF-α, IL-1β, IL-6, IL-31) - Antioxidant effects, suppressing reactive oxygen species (ROS) - Modulation of immune signaling (e.g., inhibition of NF-κB, MAPK pathways) - Downregulation of histamine release and mast cell degranulation - Barrier function and skin hydration improvement (not direct receptor action)